During the past decade, Delaware Smith Clinic conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Delaware Smith Clinic" are "Hypertension" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Delaware Smith Clinic" in a lesser frequency.

Most popular intervention types in "Delaware Smith Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "INT131 besylate" (1 trials), "PS433540" (1 trials), "Pioglitazone HCl" (1 trials), "Placebo" (1 trials) and "irbesartan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Delaware Smith Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Delaware Smith Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Delaware Smith Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Delaware Smith Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".